Literature DB >> 10377228

Novel and potent 6-chloro-3-pyridinyl ligands for the alpha4beta2 neuronal nicotinic acetylcholine receptor.

B Latli1, K D'Amour, J E Casida.   

Abstract

1-[(6-Chloro-3-pyridinyl)methyl]-2-imidazolidine (1), the N-desnitro metabolite of the major insecticide imidacloprid, is known to have similar potency to that of (-)-nicotine as an inhibitor of [3H](-)-nicotine binding at the rat recombinant alpha4beta2 neuronal nicotinic acetylcholine receptor (nAChR); IC50 values in the present study are 3.8 nM for (-)-nicotine, 6.0 nM for 1, and 155 nM for imidacloprid. Synthesis of new analogues of 1, modified only in the heterocyclic moiety (five-, six-, or seven-membered rings with NH, S, O, and CH2 substituents), gave compounds varying from 4-fold higher potency (2-iminothiazole analogue 10) to >6000-fold less active than (-)-nicotine. Other potent N-[(6-chloro-3-pyridinyl)methyl] compounds are those in which the heterocyclic imine is replaced with pyrrolidine (19) (IC50 9 nM) or trimethylammonium (22) (IC50 18 nM). A novel conversion of (-)-nicotine to its 6-chloro analogue increased the potency 2-fold. These 6-chloro-3-pyridinyl compounds are of interest as novel nAChR probes and potential metabolites of candidate insecticides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377228     DOI: 10.1021/jm980721x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  CATALYTIC ENANTIOSELECTIVE BORANE REDUCTION OF BENZYL OXIMES: PREPARATION OF (S)-1-PYRIDIN-3-YL-ETHYLAMINE BIS HYDROCHLORIDE.

Authors:  Kun Huang; Margarita Ortiz-Marciales; David Hughes
Journal:  Organic Synth       Date:  2010-01-01

2.  Imidacloprid induces morphological and molecular damages on testis of lizard (Podarcis sicula).

Authors:  Anna Cardone
Journal:  Ecotoxicology       Date:  2014-10-15       Impact factor: 2.823

3.  A Facile Approach to the Synthesis of 3,4-Disubstituted-2-Aminothiazolium Derivatives through the Use of A "Volatilizable" Support.

Authors:  Yangmei Li; Marc Giulianotti; Richard A Houghten
Journal:  Tetrahedron Lett       Date:  2010-10-27       Impact factor: 2.415

Review 4.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

5.  Highly enantioselective borane reduction of heteroaryl and heterocyclic ketoxime ethers catalyzed by novel spiroborate ester derived from diphenylvalinol: application to the synthesis of nicotine analogues.

Authors:  Kun Huang; Francisco G Merced; Margarita Ortiz-Marciales; Héctor J Meléndez; Wildeliz Correa; Melvin De Jesús
Journal:  J Org Chem       Date:  2008-05-01       Impact factor: 4.354

6.  Scaffold ranking and positional scanning utilized in the discovery of nAChR-selective compounds suitable for optimization studies.

Authors:  Jinhua Wu; Yaohong Zhang; Laura E Maida; Radleigh G Santos; Gregory S Welmaker; Travis M LaVoi; Adel Nefzi; Yongping Yu; Richard A Houghten; Lawrence Toll; Marc A Giulianotti
Journal:  J Med Chem       Date:  2013-12-12       Impact factor: 7.446

7.  Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux.

Authors:  Anna Subbotina; Aina W Ravna; Roy A Lysaa; Ruben Abagyan; Ryszard Bugno; Georg Sager
Journal:  J Pharm Pharmacol       Date:  2017-02-17       Impact factor: 3.765

8.  Discovery of Farnesoid X Receptor Antagonists Based on a Library of Oleanolic Acid 3-O-Esters through Diverse Substituent Design and Molecular Docking Methods.

Authors:  Shao-Rong Wang; Tingting Xu; Kai Deng; Chi-Wai Wong; Jinsong Liu; Wei-Shuo Fang
Journal:  Molecules       Date:  2017-04-26       Impact factor: 4.411

Review 9.  Fragment-based drug discovery: opportunities for organic synthesis.

Authors:  Jeffrey D St Denis; Richard J Hall; Christopher W Murray; Tom D Heightman; David C Rees
Journal:  RSC Med Chem       Date:  2020-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.